Selexipag塞乐西帕,475086-01-2

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Selexipag

CAS No. : 475086-01-2

MCE 国际站：Selexipag

产品活性：Selexipag (NS-304) 是一种口服有效的 前列环素 (PGI₂) 受体激动剂。

研究领域：GPCR/G Protein

作用靶点：Prostaglandin Receptor

In Vitro: Selexipag (NS-304) is an orally available and long-acting IP receptor agonist prodrug, and its active form, MRE-269, is highly selective for the IP receptor. Selexipag (NS-304) inhibits the binding of [³H]Iloprost to the human and rat IP receptors in a concentration-dependent manner. The K_i is 260 nM for the human IP receptor and 2100 nM for the rat IP receptor. The intracellular cAMP levels in hIP-CHO cells are increased in a concentration-dependent manner by treatment with Selexipag (NS-304) with EC₅₀ of 177nM. Selexipag (NS-304) also inhibits platelet aggregation in humans and monkeys with IC₅₀ values of 5.5 and 3.4 μM, respectively, but it shows no inhibition in dogs (IC₅₀ of >100 μM).

In Vivo: The C_max of MRE-269 after oral administration of NS-304 is 1.1 μg/mL in rats and 9.0 μg/mL in dogs. Selexipag (NS-304) at 1 or 3 mg/kg increases FSBF in anesthetized rats for more than 4 h after intraduodenal administration in a dose-dependent manner. In particular, Selexipag (NS-304) at 3 mg/kg causes a sustained increase in FSBF and exhibits a maximal increase of 93% in FSBF 1 h after administration.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  GPCR/G Protein Compound Library  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Drug Repurposing Compound Library  |  Anti-Cardiovascular Disease Compound Library  |  Endocrinology Compound Library  |  Anti-COVID-19 Compound Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Angiogenesis-Related Compound Library  |  Rare Diseases Drug Library  |  Children’s Drug Library  |  EMA-Approved Drug Library  |  Human Metabolite Library  |  Coagulation and Anti-coagulation Compound Library  |  Off-patent Drug Library  |  Membrane Protein-targeted Compound Library  |  Membrane Receptor-targeted Compound Library  |  Highly Selective Activators Library  |  Prostaglandin E2  |  EIPA  |  Prostaglandin E1  |  Tranilast  |  PF-04418948  |  U-46619  |  Iloprost  |  Prostaglandin D2  |  ONO-AE3-208  |  Dinoprost  |  Palupiprant  |  Latanoprost  |  16,16-Dimethyl prostaglandin E2  |  Treprostinil  |  DG-041  |  Grapiprant  |  L-798106  |  GW627368  |  Fevipiprant  |  Asapiprant  |  AH 6809  |  L-161982  |  Laropiprant  |  Bimatoprost  |  CJ-42794  |  MF498  |  Beraprost sodium  |  Ramatroban  |  Travoprost

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds